The virulence of enterotoxigenic Escherichia coli (ETEC) is attributed to their ability to adhere via fimbrial adhesins to specific receptors located on the intestinal mucosa. A novel approach to preventing ETEC induced diarrhoea would be to prevent attachment of ETEC to intestine by proteolytically modifying the receptor attachment sites. This study aimed to examine the effect of bromelain, a proteolytic extract obtained from pineapple stems, on ETEC receptor activity in porcine small intestine. Bromelain was administered orally to piglets and K88+ ETEC attachment to small intestine was measured at 50 cm intervals using an enzyme immunoassay. K88+ ETEC attachment to intestinal sections that were not treated with bromelain varied appreciably between sampling sites. Variability in receptor activity along the intestinal surface is thought to be caused by the localised effects of endogenous proteases. Oral administration of exogenous protease inhibited K88+ ETEC attachment to pig small intestine in a dose dependent manner (p<0.05). Attachment of K88+ ETEC was negligible after treatment, resembling the levels of attachment of K88 to piglets of the genetically determined non-adhesive phenotype, which are resistant to K88+ ETEC infection. Serum biochemical analysis and histopathological examination of treated piglets showed no adverse effects ofthe bromelain treatment. It is concluded that administration of bromelain can inhibit ETEC receptor activity in vivo and may therefore be useful for prevention of K88+ ETEC induced diarrhoea.
Enterotoxigenic Escherichia coli (ETEC) are an important cause of disease in young children' and young animals. 2 The virulence of ETEC strains is attributed to their ability to adhere, via fimbrial adhesins, to highly specific receptors located on the intestinal mucosa.3 These strains also liberate heat labile (LT) and/or heat stable (ST) enterotoxins which cause fluid secretion and diarrhoea. E coli strains which carry the K88 adhesin on their surface are a significant cause of diarrhoea in young piglets.4 K88 occurs in several antigenic types or variants, all of which adhere to piglet enterocytes.5 K88ab, K88ac, K88ad, and K88ad(e) variants have been characterised.6 7 In 1975, Rutter et al 8 showed that some pigs are resistant to colonisation and disease caused by K88-positive (K88+) E coli. An adhesive phenotype (one susceptible to infection) is related directly to the ability of K88+ bacteria to recognise intestinal receptors and attach to piglet intestinal brush border membranes. Intestine obtained from the non-adhesive phenotype (disease resistant pigs) do not bind K88+ E coli and as a result such animals are resistant to K88+ E coli infection. 9 The receptors on non-adhesive intestinal brush border cells may be absent or non-functional. A genetic basis for expression of the adhesive or non-adhesive phenotype exists.8 10 Different phenotypes may also be distinguished, depending on the serological variant of the K88 antigen."1 Also, in addition to genotype, physiological factors, particularly the level of intestinal proteolysis within the small intestine, may influence the ability of ETEC to attach to intestine.12 13 The ability of protease to prevent attachment of ETEC to small intestinal samples in vitro is well documented. 13-18 Presumably attachment ability is prevented because of proteolytic cleavage of ETEC receptor sites. This study aimed to investigate whether exogenous protease, administered orally, could inhibit porcine K88+ ETEC receptor activity in vivo and therefore inhibit K88+ ETEC attachment to small intestine. The use of protease, through its ability to modify intestinal receptor sites and reduce the binding properties of the intestinal mucosa, may be an important way of protecting the small intestine from microbial colonisation and disease. 12 Table.) SERUM BIOCHEMISTRY Blood samples (10 ml) were collected from piglets via the jugular vein one day before experimentation and again immediately before death. Serum samples were stored at -20°C until completion of the experiment, at which time they were submitted for biochemical analysis. Tests performed include a full biochemical profile, liver function tests, creatinine kinase, lipase, and amylase. As normal values for biochemical parameters cited in the literature vary because of factors such as differences in sample handling, assay technique, dietary influences or genetic differences between animals, pre-treatment values were taken as an indication of baseline normal values. These values were within the normal ranges cited in the literature.22 23 Differences between serum samples before and after treatment were compared for each pig. In addition, the mean serum value for each parameter for the treated groups was compared with that for the nontreatment group.
HISTOPATHOLOGY
All animals were sacrificed by barbiturate overdose two or five days after beginning treatment. At autopsy, specimens were immediately processed for histological examination after fixation with neutral buffered formalin (0.65% (w/v) Na2HPO4, 0.45 (w/v) NaH2PO4, 10% (v/v) formalin). Sections of duodenum, midjejunum, and ileum, were stained with haematoxylin and eosin and examined by light microscopy for morphological changes. Sections of heart, kidney, liver, and mesenteric lymph nodes were also investigated.
STATISTICAL ANALYSIS
Differences in biochemical parameters, between serum samples, before and after treatment, and differences between treatment groups were assessed for clinical relevance by veterinary pathologists at VIAS-Attwood. Differences among mean serum biochemical values between treatment groups were subjected to one-way analysis of variance (ANOVA) using Microstat. Difference among mean EIA values for all treatment groups (0 mg to 1250 mg) representing mean K88+ ETEC receptor activity was analysed by Genestat V for analysis of variance.
Results

K88+ ETEC ATTACHMENT TO SMALL INTESTINE OF UNTREATED (CONTROL PIGS)
We first examined the ability of K88+ ETEC to attach to the small intestine of pigs that were not treated with bromelain (group A). The Table summarises the results obtained from all untreated pigs. Two pigs were of the strongly adhesive phenotype, three pigs were moderately adhesive and two pigs were of nonadhesive phenotype. Figure 1 shows EIA values obtained from intestine of three pigs to show the three phenotypes obtained.
We next compared the binding of K88+ ETEC to different sections of intestine in individual pigs. K88+ ETEC attachment to intestine varied markedly between samples taken at 50 cm intervals (Fig 1) . Multiple scrapings taken at the same site revealed similar results indicating that the variability between sites was a function of that section of intestine, not the assay. Earlier, Chandler et al 13 observed a similar variation in binding between sampling sites and related this variation to the state of distention or constriction of the small intestine at the sampling site. and after treatment (data not shown recognise and attach to the small intestinal brush border.
The pattern of non-adhesiveness observed in protease treated pigs resembled that observed in pigs of the genetically determined, non-adhesive phenotype. Piglets of the nonadhesive phenotype are resistant to K88+ ETEC infection because they lack functional receptors for ETEC.8 9 Therefore, the inability of K88+ bacteria to recognise receptor sites on the small intestine of bromelain treated piglets should render the animals resistant to colonisation by these bacteria and prevent diarrhoeal disease. We have previously shown that the oral administration of enteric-coated bromelain to rabbits inhibits colonisation of CFA/I+ ST+LT+ E coli (HI 0407) and protects against diarrhoea and diarrhoea induced death. '2 Further studies have demonstrated that bromelain significantly reduces diarrhoea in piglets challenged with K88+ ETEC (Chandler and Mynott, manuscript in preparation).
The data in this study support the view that increased proteolytic activity in the intestine favours low receptor activity, and hence resistance to ETEC colonisation. In addition to acidity in the stomach, local intestinal immunity, the flushing action of intestinal peristalsis, and competition with commensal organisms, intestinal proteolysis may be a previously undescribed host-defense mechanism. The novel concept of host receptor modification by oral administration of protease is a new approach to disease control that could provide broad spectrum protection and obviate the potential difficulty of antigenic variability of microbial virulence determinants.
